- ·Watch FlightPath (Drug Discovery): the Monday email on marks, rounds and moves
FlightPath (Drug Discovery) funding history
No funding rounds for FlightPath (Drug Discovery) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
FlightPath (Drug Discovery) valuation
FlightPath (Drug Discovery)'s last known valuation is $21 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How FlightPath (Drug Discovery)'s valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For FlightPath (Drug Discovery), too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about FlightPath (Drug Discovery)
- What is FlightPath (Drug Discovery) worth?
- FlightPath (Drug Discovery)'s last known valuation is $21.0M.
- How much has FlightPath (Drug Discovery) raised?
- FlightPath (Drug Discovery) has raised $9.7M in total funding across its recorded rounds.